Clinical Research

Early SAVR in asymptomatic heart patients linked to long-term benefits
New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.
New data point to LAAO as a safe alternative to long-term drug therapy
At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.
PFA associated with heightened stroke risk
PFA is still quite safe overall. However, new data out of EHRA 2026 suggest cardiologists have much to learn about minimizing risk during treatment.
Ultraprocessed foods may degrade muscle health, new MRI findings suggest
High consumption of these foods could lead to increased levels of intramuscular fat—a known marker of poor muscle health, according to new research published in Radiology.
Outgoing SCAI president reflects on a busy year full of partnerships and advocacy
SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months.

"Imaging skins" could improve surgical removal of cancerous tumors.

How 'imaging skins' could improve surgical precision in oncology settings

The novel X-ray detector was designed to be integrated into a custom imaging system that converts radiation into light.

doctor wrong patient wrong-site surgery medical error malpractice mistake

Not all radiologists are buying what AI is selling, even when the technology outperforms humans

Providers are up to three times more likely to trust the opinion of humans over AI, even when the algorithm is proven to detect more cancerous lesions than radiologists.

Raj Makkar, MD, director, interventional cardiology, director, Interventional Cardiology Research Program and professor of medicine, Smidt Heart Institute, Cedars-Sinai Hospital, presented the late-breaking Align-AR clinical trial at ACC 2025 on the first 500 patients treated for aortic regurgitation using the Jena Valve transcatheter aortic valve replacement (TAVR) device.

First 500 patients in Align-AR trial using TAVR for pure aortic regurgitation show strong outcomes

Raj Makkar, MD, Cedars-Sinai, explains the late-breaking data from the Align-AR trial on the first 500 patients treated for aortic regurgitation using the Jena Valve TAVR device.